Nicola Napoli et all, Effects of Teriparatide in Patiens with Osteoporosis in Clinical Practice: 42 –Month Results During and After Discontinuation of Treatment From the European Extended Forsteo Observational Study (ExFOS), Calcif Tissue int, 103 (4), 35

Kendler L D, et all, Publishing online, November 9, 2017, Effects of teriparatide and risedronate on new fractures in post- menopausal Women with severe osteoporosis (VERO) a multicenter, double-blind, double-dummy, randomized controlled trial.